#future of pharmaceutical industry
- Strathprints home
- Open Access
Research under the microscope.
The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs.
Strathprints serves world leading Open Access research by the University of Strathclyde, including research by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), where research centres such as the Industrial Biotechnology Innovation Centre (IBioIC), the Cancer Research UK Formulation Unit, SeaBioTech and the Centre for Biophotonics are based.
Four scenarios for the future of the pharmaceutical industry
Bradfield, Ron M. and El-Sayed, Hany (2009) Four scenarios for the future of the pharmaceutical industry. Technology Analysis and Strategic Management, 21 (2). pp. 195-212. ISSN 1465-3990
Pharmaceutical companies are facing several major interrelated challenges, the most strategic being the decline in R D productivity resulting in empty product pipelines to replace products nearing patent expiry. A common response has been mergers and acquisition of competitors and biotechnology firms, but rather than resolving the problems, this has created new ones. While biotechnology promises to reshape the pharmaceutical industry, it too faces challenges: the industry as a whole is unprofitable and there is uncertainty regarding market acceptance of its products. This paper examines the current issues in the two industries, and describes a scenario process resulting in the development of a set of scenarios depicting four possible future paths along which the pharmaceutical industry may develop over the next 15 years.